Alsayed, M., El-Kady, D., tantawy, M., AbdElhalim, M., Elazabawy, S., Abdallah, A., Elmegeed, G. (2021). Novel Melatonin Derivatives: Synthesis, Anticancer Evaluations and Molecular-Docking Study. Egyptian Journal of Chemistry, 64(3), 10-11. doi: 10.21608/ejchem.2020.49430.3016
Mahmoud Alsayed; Dina S. El-Kady; mohamed A tantawy; Mervat M. AbdElhalim; Samia R. Elazabawy; Amira E. M. Abdallah; Gamal A Elmegeed. "Novel Melatonin Derivatives: Synthesis, Anticancer Evaluations and Molecular-Docking Study". Egyptian Journal of Chemistry, 64, 3, 2021, 10-11. doi: 10.21608/ejchem.2020.49430.3016
Alsayed, M., El-Kady, D., tantawy, M., AbdElhalim, M., Elazabawy, S., Abdallah, A., Elmegeed, G. (2021). 'Novel Melatonin Derivatives: Synthesis, Anticancer Evaluations and Molecular-Docking Study', Egyptian Journal of Chemistry, 64(3), pp. 10-11. doi: 10.21608/ejchem.2020.49430.3016
Alsayed, M., El-Kady, D., tantawy, M., AbdElhalim, M., Elazabawy, S., Abdallah, A., Elmegeed, G. Novel Melatonin Derivatives: Synthesis, Anticancer Evaluations and Molecular-Docking Study. Egyptian Journal of Chemistry, 2021; 64(3): 10-11. doi: 10.21608/ejchem.2020.49430.3016
Novel Melatonin Derivatives: Synthesis, Anticancer Evaluations and Molecular-Docking Study
1Department of Chemistry, Faculty of Science, Helwan University; Ain Helwan, Cairo 11795, A. R. Egypt
2Hormones Department, Medical Research Division, National Research Centre, Dokki, Giza, Egypt
3Ain Helwan
Receive Date: 13 November 2020,
Revise Date: 09 December 2020,
Accept Date: 20 December 2020
Abstract
Many studies mentioned that Melatonin considers an anti-cancer agent. So in this study, a lot of novel Melatonin derivatives incorporated different heterocyclic ring systems such as triazole, thiadiazole, tetrazole, thiazole, thiophene and pyrazole were synthesized. The synthesized compounds 5, 6, 8, 11, 15, 16 and 19 were evaluated as anti-cancer by using two human cancer cell lines, Breast cancer (MCF7) and colon cancer (HCT-116). The synthesized compounds showed a gradual decrease in the cell viability of the two cell lines. We also observed that compound 16 was the lowest IC50 and the highest cytotoxic effects against the two cancer cell lines. Furthermore, the molecular-docking study was employed to determine the possible mode of action of the synthesized compounds against proteins (CDK2 and P53-MDM2) which, were considered to be potential proteins involved in the pathogenesis of cancer. We observed that compound 16 was the best-docked ligand against the targeted proteins, as it displayed the lowest binding energies, critical hydrogen bonds, and hydrophobic interactions compared to other tested compounds.
Top